Alternate-Day Buprenorphine. Phase V - 6
Phase 1
Completed
- Conditions
- Opioid-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00000224
- Locations
- ๐บ๐ธ
Treatment Research Center, Burlington, Vermont, United States
Effects of Nefazodone on Treatment of Female Cocaine Abusers - 3
Phase 2
Completed
- Conditions
- Cocaine-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00000286
- Locations
- ๐บ๐ธ
University of Minnesota, Minneapolis, Minnesota, United States
Effects of Phenytoin on Cocaine Use in Humans - 2
Phase 1
Completed
- Conditions
- Cocaine-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00000285
- Locations
- ๐บ๐ธ
University of Minnesota, Minneapolis, Minnesota, United States
Infusion Laboratory: Protocol 1 - Selegeline - 2
Phase 1
Completed
- Conditions
- Cocaine-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00000337
- Locations
- ๐บ๐ธ
Friends Research Institute, Los Angeles, California, United States
Risperidone for Treatment of Cocaine Dependence in Outpatients - 12
Phase 2
Completed
- Conditions
- Cocaine-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00000347
- Locations
- ๐บ๐ธ
Friends Research Institute, Los Angeles, California, United States
Role of Metabolites in Nicotine Dependence (2) - 5
Phase 2
Completed
- Conditions
- Tobacco Use Disorder
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00000288
- Locations
- ๐บ๐ธ
University of Minnesota, Minneapolis, Minnesota, United States
Treatment Efficacy for Drug Abuse and AIDS Prevention - 1
Phase 2
Completed
- Conditions
- Heroin DependenceCocaine-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00000210
- Locations
- ๐บ๐ธ
McLean Hospital, Dept. of Psychiatry, Belmont, Massachusetts, United States
Effect of Nefazodone on Relapse in Females With Cocaine Abuse - 10
Phase 3
Completed
- Conditions
- Cocaine-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00000293
- Locations
- ๐บ๐ธ
University of Minnesota, Minneapolis, Minnesota, United States
Cognitive Correlates of Substance Abuse, Part 2 - 16
- Conditions
- Amphetamine-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-11
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 43
- Registration Number
- NCT00000351
- Locations
- ๐บ๐ธ
Friends Research Institute, Los Angeles, California, United States
Evaluation of Benztropine for Cocaine Craving - 2
Phase 2
Completed
- Conditions
- Cocaine-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-02-24
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00000333
- Locations
- ๐บ๐ธ
Washington DC VA, Washington, District of Columbia, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath